Azzad Asset Management Inc. ADV decreased its position in The Clorox Company (NYSE:CLX – Free Report) by 0.7% during the 1st quarter, Holdings Channel reports. The firm owned 16,681 shares of the company’s stock after selling 117 shares during the period. Azzad Asset Management Inc. ADV’s holdings in Clorox were worth $2,554,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently made changes to their positions in CLX. Point72 Asset Management L.P. bought a new position in shares of Clorox in the fourth quarter worth approximately $144,844,000. Norges Bank purchased a new stake in Clorox in the fourth quarter worth $128,382,000. Parsifal Capital Management LP purchased a new stake in Clorox in the fourth quarter worth $128,245,000. Confluence Investment Management LLC purchased a new stake in Clorox in the first quarter worth $135,630,000. Finally, International Assets Investment Management LLC lifted its stake in Clorox by 17,658.5% in the fourth quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after acquiring an additional 481,725 shares during the period. Institutional investors own 78.53% of the company’s stock.
Clorox Price Performance
CLX opened at $132.56 on Thursday. The stock has a 50-day moving average price of $136.49 and a 200-day moving average price of $143.67. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.53. The firm has a market cap of $16.46 billion, a PE ratio of 68.68, a P/E/G ratio of 2.19 and a beta of 0.39. The Clorox Company has a 1 year low of $114.68 and a 1 year high of $169.14.
Analyst Ratings Changes
A number of analysts recently commented on CLX shares. UBS Group dropped their price target on Clorox from $164.00 to $159.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. JPMorgan Chase & Co. dropped their price target on Clorox from $159.00 to $158.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. Evercore ISI dropped their price target on Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research note on Wednesday, May 1st. Citigroup dropped their price target on Clorox from $155.00 to $150.00 and set a “neutral” rating for the company in a research note on Wednesday, May 1st. Finally, BNP Paribas began coverage on Clorox in a research note on Monday, June 24th. They issued an “underperform” rating and a $130.00 price target for the company. Five equities research analysts have rated the stock with a sell rating and fourteen have issued a hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $145.33.
Check Out Our Latest Analysis on CLX
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- Best Aerospace Stocks Investing
- AbbVie Stock: A Perfect Dip for Investors to Buy
- How Investors Can Find the Best Cheap Dividend Stocks
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- The Role Economic Reports Play in a Successful Investment Strategy
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.